Wang M, Lindberg J, Klevebring D, Nilsson C, Mer AS, Rantalainen M, Lehmann S, Gronberg H. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling. Leukemia. 2017;31(10):2029–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pastore F, Dufour A, Benthaus T, Metzeler KH, Maharry KS, Schneider S, Ksienzyk B, Mellert G, Zellmeier E, Kakadia PM, et al. Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia. J Clin Oncol. 2014;32(15):1586–94.

Article  PubMed  PubMed Central  Google Scholar 

Itzykson R, Fournier E, Berthon C, Rollig C, Braun T, Marceau-Renaut A, Pautas C, Nibourel O, Lemasle E, Micol JB, et al. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood. 2021;138(7):507–19.

Article  CAS  PubMed  Google Scholar 

Short NJ, Macaron W, Kadia T, Dinardo C, Issa GC, Daver N, Wang S, Jorgensen J, Nguyen D, Bidikian A, et al. Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. Am J Hematol. 2022;97(11):E408–11.

Article  PubMed  Google Scholar 

Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539–47.

Article  PubMed  Google Scholar 

Nakamura N, Ninomiya S, Matsumoto T, Nakamura H, Kitagawa J, Shiraki M, Hara T, Shimizu M, Tsurumi H. Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia. Ann Hematol. 2019;98(2):351–9.

Article  PubMed  Google Scholar 

Jung J, Lee E, Shim H, Park JH, Eom HS, Lee H. Prediction of clinical outcomes through assessment of Sarcopenia and Adipopenia using computed tomography in adult patients with acute myeloid leukemia. Int J Hematol. 2021;114(1):44–52.

Article  CAS  PubMed  Google Scholar 

Sun Q, Cui J, Liu W, Li J, Hong M, Qian S. The Prognostic Value of Sarcopenia in Acute myeloid leukemia patients and the development and validation of a Novel Nomogram for Predicting Survival. Front Oncol. 2022;12:828939.

Article  PubMed  PubMed Central  Google Scholar 

Suzuki D, Kobayashi R, Sano H, Hori D, Kobayashi K. Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance. Int J Hematol. 2018;107(4):486–9.

Article  PubMed  Google Scholar 

Yi X, Chen Q, Yang J, Jiang D, Zhu L, Liu H, Pang P, Zeng F, Chen C, Gong G, et al. CT-Based Sarcopenic Nomogram for Predicting Progressive Disease in Advanced Non-small-cell Lung Cancer. Front Oncol. 2021;11:643941.

Article  PubMed  PubMed Central  Google Scholar 

Xu F, Zhang L, Wang Z, Han D, Li C, Zheng S, Yin H, Lyu J. A New Scoring System for Predicting In-hospital death in patients having liver cirrhosis with esophageal varices. Front Med (Lausanne). 2021;8:678646.

Article  PubMed  Google Scholar 

Li C, Yang J, Xu F, Han D, Zheng S, Kaaya RE, Wang S, Lyu J. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and end results database. BMC Cancer. 2020;20(1):534.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seban RD, Rouzier R, Latouche A, Deleval N, Guinebretiere JM, Buvat I, Bidard FC, Champion L. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer. Eur J Nucl Med Mol Imaging. 2021;48(11):3560–70.

Article  CAS  PubMed  Google Scholar 

Vucinic V, Ruhnke L, Sockel K, Rohnert MA, Backhaus D, Brauer D, Franke GN, Niederwieser D, Bornhauser M, Rollig C, et al. The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia. Blood Adv. 2021;5(24):5584–7.

Article  PubMed  PubMed Central  Google Scholar 

Salvagno GL, Sanchis-Gomar F, Picanza A, Lippi G. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86–105.

Article  PubMed  Google Scholar 

Pabst T, Kortz L, Fiedler GM, Ceglarek U, Idle JR, Beyoglu D. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features. BBA Clin. 2017;7:105–14.

Article  PubMed  PubMed Central  Google Scholar 

Pandyra AA, Mullen PJ, Goard CA, Ericson E, Sharma P, Kalkat M, Yu R, Pong JT, Brown KR, Hart T, et al. Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell death. Oncotarget. 2015;6(29):26909–21.

Article  PubMed  PubMed Central  Google Scholar 

van Besien H, Sassano A, Altman JK, Platanias LC. Antileukemic properties of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Leuk Lymphoma. 2013;54(12):2601–5.

Article  PubMed  Google Scholar